MRK - Merck & Co., Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue39,807,00039,498,00042,237,000
Cost of Revenue13,891,00014,934,00016,768,000
Gross Profit25,916,00024,564,00025,469,000
Operating Expenses
Research Development10,124,0006,704,0007,180,000
Selling General and Administrative9,762,00010,313,00011,606,000
Non Recurring651,000619,0001,013,000
Others---
Total Operating Expenses---
Operating Income or Loss5,379,0006,928,0005,670,000
Income from Continuing Operations
Total Other Income/Expenses Net-720,000-1,527,00011,613,000
Earnings Before Interest and Taxes4,659,0005,401,00017,283,000
Interest Expense---
Income Before Tax4,659,0005,401,00017,283,000
Income Tax Expense718,000942,0005,349,000
Minority Interest220,00091,000144,000
Net Income From Continuing Ops3,920,0004,442,00011,920,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income3,920,0004,442,00011,920,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares3,920,0004,442,00011,920,000